Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health SystemStephen B. Williams, Stephen J. Freedland, Lauren E. Howard et al.|JAMA Network Open|2021Cited by 62
Predictors of skeletal‐related events and mortality in men with metastatic, castration‐resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseIngrid Lorese Tablazon, Stephen B. Williams, Lauren E. Howard et al.|Cancer|2019Cited by 23
Exposure to Agent Orange and Risk of Bladder Cancer Among US VeteransStephen B. Williams, Stephen J. Freedland, Jacques Baillargeon et al.|JAMA Network Open|2023Cited by 16
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patientsSungyong You, Stephen B. Williams, Minhyung Kim et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 15
Identification of Patients With Metastatic Prostate Cancer With Natural Language Processing and Machine LearningRuixin Yang, Zachary Klaassen, Di Zhu et al.|JCO Clinical Cancer Informatics|2022Cited by 14